| Literature DB >> 25897197 |
Chui-Lien Tsen1, Yu-Harn Horng1, Shwu-Jiuan Sheu2.
Abstract
BACKGROUND: We describe the anatomical and functional outcomes of eyes that underwent a modified technique of relaxing retinotomy, dashed line relaxing retinotomy, in the management of retinal detachment with anterior proliferative vitreoretinopathy.Entities:
Keywords: PFCL; perfluorocarbon liquid
Year: 2015 PMID: 25897197 PMCID: PMC4396421 DOI: 10.2147/OPTH.S79905
Source DB: PubMed Journal: Clin Ophthalmol ISSN: 1177-5467
Figure 1Procedure of dashed line relaxing retinotomy.
Notes: (A) Complete removal of all the epiretinal or subretinal membrane was done after pars plana vitrectomy. (B) Diathermy was applied to the entire area to be cut in a dashed line pattern. (C) The relaxing retinotomy was completed by gently tearing the dashed line diathermy on the retina under air phase after fluid gas exchange through a preexisting break or a drainage retinotomy. (D) Excision of anterior flap of retinotomy was done under air or silicone oil. (E) Laser endophotocoagulation then can be applied to the edges of the retinotomy, if possible, including the anterior margin of the retinotomy.
Baseline patients and characteristics (n=54)
| Mean age, SD (range), years | 51.3±16.2 (67) |
| Sex, number (%) | |
| Male | 35 (67) |
| Female | 17 (33) |
| Best-corrected visual acuity, number (%) | |
| >counting fingers | 21 (39) |
| Counting fingers | 10 (18) |
| Hand motions | 21 (39) |
| Light perception | 2 (4) |
| Lens status, number (%) | |
| Phakic | 29 (54) |
| Pseudophakic | 24 (44) |
| Aphakic | 1 (2) |
| Extent of RD, quadrants, number (%) | |
| ≤3 quadrants | 20 (37) |
| 4 quadrants | 34 (63) |
| Macula involvement, number (%) | |
| Macula on | 14 (26) |
| Macula off | 40 (74) |
| PVR classification, number (%) | |
| Grade C (A) | 26 (48) |
| Grade C (A+P) | 28 (52) |
| Diagnosis, number (%) | |
| Primary RD | 12 (22) |
| Recurrent RD | 28 (52) |
| RD secondary to other cause (PDR, endophthalmitis, trauma) | 14 (26) |
| Previous surgery, number (%) | |
| VT + SB | 14 (26) |
| VT | 22 (41) |
| SB | 3 (6) |
| Cataract extraction | 25 (46) |
Abbreviations: C (A), grade C proliferative vitreoretinopathy (anterior); C (A+P), grade C proliferative vitreoretinopathy (anterior + posterior); PDR, proliferative diabetic retinopathy; PVR, proliferative vitreoretinopathy; RD, retinal detachment; SB, scleral buckling; SD, standard deviation; VT, vitrectomy.
Anatomic and visual outcome (n=54)
| Primary RD | Recurrent RD | RD secondary to other cause | Total | |
|---|---|---|---|---|
| Success, number (%) | ||||
| Initial reattachment | 8 (67) | 22 (79) | 9 (64) | 39 (72) |
| Final reattachment | 11 (92) | 28 (100) | 13 (93) | 52 (96) |
| Postoperative BCVA, number (%) | ||||
| Stable or improved | 10 (83) | 21 (75) | 8 (57) | 39 (72) |
| Worse | 2 (17) | 7 (25) | 6 (43) | 15 (28) |
| Postoperative complication, number (%) | ||||
| Hypotony (IOP <5 mmHg) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Secondary glaucoma (IOP >25 mmHg) | 2 (17) | 5 (18) | 1 (7) | 8 (15) |
Abbreviations: BCVA, best-corrected visual acuity; IOP, intraocular pressure; RD, retinal detachment.
Factors may influence the anatomical outcome
| Initial reattachment n=39 (%) | Final reattachment n=52 (%) | |||
|---|---|---|---|---|
| Sex | ||||
| Female | 12 (30.8) | 0.536 | 17 (32.7) | 1.000 |
| Male | 27 (69.2) | 35 (67.3) | ||
| Initial BCVA | ||||
| ≤CF | 24 (61.5) | 1.000 | 31 (59.6) | 0.516 |
| >CF | 15 (38.5) | 21 (40.4) | ||
| Extent of RD | ||||
| ≤3 quadrant | 15 (38.5) | 1.000 | 20 (38.5) | 0.525 |
| 4 quadrant | 24 (61.5) | 32 (61.5) | ||
| Macula involvement | ||||
| Macula off | 29 (74.4) | 1.000 | 38 (73.1) | 1.000 |
| Macula on | 10 (25.6) | 14 (26.9) | ||
| PVR | ||||
| C (A) | 18 (46.2) | 0.764 | 25 (48.1) | 1.000 |
| C (A+P) | 21 (53.8) | 27 (51.9) | ||
| RR size | ||||
| <180° | 27 (69.2) | 0.302 | 38 (73.1) | 1.000 |
| ≥180° | 12 (30.8) | 14 (26.9) | ||
| Intraocular tamponade | ||||
| Silicone oil | 29 (74.4) | <0.001 | 28 (53.8) | 0.497 |
| C3F8 | 10 (25.6) | 24 (46.2) | ||
| PFCL | ||||
| No PFCL | 28 (71.8) | 0.311 | 40 (76.9) | 0.427 |
| PFCL | 11 (28.2) | 12 (23.1) | ||
Note:
Represents statistical significance.
Abbreviations: BCVA, best-corrected visual acuity; C3F8, octafluoropropane; C (A), grade C proliferative vitreoretinopathy (anterior); C (A+P), grade C proliferative vitreoretinopathy (anterior + posterior); CF, counting finger; PFCL, perfluorocarbon liquid; PVR, proliferative vitreoretinopathy; RD, retinal detachment; RR, relaxing retinotomy.